Signaling events required for transforming growth factor-β stimulation of connective tissue growth factor expression by cultured human lung fibroblasts

U. Kucich, J. C. Rosenbloom, D. J. Herrick, W. R. Abrams, Andrew Hamilton, S. M. Sebti, J. Rosenbloom

Research output: Contribution to journalArticle

Abstract

It is possible that many of the fibrogenic effects of transforming growth factor-β (TGF-β) are mediated by connective tissue growth factor (CTGF). In the present work, we show that TGF-β1 produces a 5- to 6-fold increase in CTGF expression by cultured human lung fibroblasts that is due mainly to increased transcription. The half-life of CTGF mRNA is 1.96 h, consistent with its role as a cytokine. In addition to requiring Smad activity, based upon the effects of specific inhibitors, the TGF-β intracellular signaling pathway requires the activity of a phosphatidylcholine-specific phospholipase C, a protein kinase C, and one or more tyrosine kinases. It is also likely that the pathway requires a member of the Ras superfamily of small GTPases, but not trimeric G proteins. Pharmacologic inhibition of TGF-β stimulation of CTGF expression may be an effective therapeutic approach to a variety of undesirable fibrotic reactions.

Original languageEnglish (US)
Pages (from-to)103-112
Number of pages10
JournalArchives of Biochemistry and Biophysics
Volume395
Issue number1
DOIs
StatePublished - Nov 1 2001

Fingerprint

Connective Tissue Growth Factor
Transforming Growth Factors
Fibroblasts
Lung
Monomeric GTP-Binding Proteins
Transcription
GTP-Binding Proteins
Protein-Tyrosine Kinases
Protein Kinase C
Half-Life
Cytokines
Messenger RNA

Keywords

  • Connective tissue growth factor
  • Prenylation
  • Protein kinase C
  • Signaling
  • Transforming growth factor-β

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Signaling events required for transforming growth factor-β stimulation of connective tissue growth factor expression by cultured human lung fibroblasts. / Kucich, U.; Rosenbloom, J. C.; Herrick, D. J.; Abrams, W. R.; Hamilton, Andrew; Sebti, S. M.; Rosenbloom, J.

In: Archives of Biochemistry and Biophysics, Vol. 395, No. 1, 01.11.2001, p. 103-112.

Research output: Contribution to journalArticle

Kucich, U. ; Rosenbloom, J. C. ; Herrick, D. J. ; Abrams, W. R. ; Hamilton, Andrew ; Sebti, S. M. ; Rosenbloom, J. / Signaling events required for transforming growth factor-β stimulation of connective tissue growth factor expression by cultured human lung fibroblasts. In: Archives of Biochemistry and Biophysics. 2001 ; Vol. 395, No. 1. pp. 103-112.
@article{0b405fe102da438cad3f456ba5aa1a73,
title = "Signaling events required for transforming growth factor-β stimulation of connective tissue growth factor expression by cultured human lung fibroblasts",
abstract = "It is possible that many of the fibrogenic effects of transforming growth factor-β (TGF-β) are mediated by connective tissue growth factor (CTGF). In the present work, we show that TGF-β1 produces a 5- to 6-fold increase in CTGF expression by cultured human lung fibroblasts that is due mainly to increased transcription. The half-life of CTGF mRNA is 1.96 h, consistent with its role as a cytokine. In addition to requiring Smad activity, based upon the effects of specific inhibitors, the TGF-β intracellular signaling pathway requires the activity of a phosphatidylcholine-specific phospholipase C, a protein kinase C, and one or more tyrosine kinases. It is also likely that the pathway requires a member of the Ras superfamily of small GTPases, but not trimeric G proteins. Pharmacologic inhibition of TGF-β stimulation of CTGF expression may be an effective therapeutic approach to a variety of undesirable fibrotic reactions.",
keywords = "Connective tissue growth factor, Prenylation, Protein kinase C, Signaling, Transforming growth factor-β",
author = "U. Kucich and Rosenbloom, {J. C.} and Herrick, {D. J.} and Abrams, {W. R.} and Andrew Hamilton and Sebti, {S. M.} and J. Rosenbloom",
year = "2001",
month = "11",
day = "1",
doi = "10.1006/abbi.2001.2571",
language = "English (US)",
volume = "395",
pages = "103--112",
journal = "Archives of Biochemistry and Biophysics",
issn = "0003-9861",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Signaling events required for transforming growth factor-β stimulation of connective tissue growth factor expression by cultured human lung fibroblasts

AU - Kucich, U.

AU - Rosenbloom, J. C.

AU - Herrick, D. J.

AU - Abrams, W. R.

AU - Hamilton, Andrew

AU - Sebti, S. M.

AU - Rosenbloom, J.

PY - 2001/11/1

Y1 - 2001/11/1

N2 - It is possible that many of the fibrogenic effects of transforming growth factor-β (TGF-β) are mediated by connective tissue growth factor (CTGF). In the present work, we show that TGF-β1 produces a 5- to 6-fold increase in CTGF expression by cultured human lung fibroblasts that is due mainly to increased transcription. The half-life of CTGF mRNA is 1.96 h, consistent with its role as a cytokine. In addition to requiring Smad activity, based upon the effects of specific inhibitors, the TGF-β intracellular signaling pathway requires the activity of a phosphatidylcholine-specific phospholipase C, a protein kinase C, and one or more tyrosine kinases. It is also likely that the pathway requires a member of the Ras superfamily of small GTPases, but not trimeric G proteins. Pharmacologic inhibition of TGF-β stimulation of CTGF expression may be an effective therapeutic approach to a variety of undesirable fibrotic reactions.

AB - It is possible that many of the fibrogenic effects of transforming growth factor-β (TGF-β) are mediated by connective tissue growth factor (CTGF). In the present work, we show that TGF-β1 produces a 5- to 6-fold increase in CTGF expression by cultured human lung fibroblasts that is due mainly to increased transcription. The half-life of CTGF mRNA is 1.96 h, consistent with its role as a cytokine. In addition to requiring Smad activity, based upon the effects of specific inhibitors, the TGF-β intracellular signaling pathway requires the activity of a phosphatidylcholine-specific phospholipase C, a protein kinase C, and one or more tyrosine kinases. It is also likely that the pathway requires a member of the Ras superfamily of small GTPases, but not trimeric G proteins. Pharmacologic inhibition of TGF-β stimulation of CTGF expression may be an effective therapeutic approach to a variety of undesirable fibrotic reactions.

KW - Connective tissue growth factor

KW - Prenylation

KW - Protein kinase C

KW - Signaling

KW - Transforming growth factor-β

UR - http://www.scopus.com/inward/record.url?scp=0035498841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035498841&partnerID=8YFLogxK

U2 - 10.1006/abbi.2001.2571

DO - 10.1006/abbi.2001.2571

M3 - Article

C2 - 11673871

AN - SCOPUS:0035498841

VL - 395

SP - 103

EP - 112

JO - Archives of Biochemistry and Biophysics

JF - Archives of Biochemistry and Biophysics

SN - 0003-9861

IS - 1

ER -